Appropriated funds for Office of Generic Drugs dries up

Share this article:
FDA's Office of Generic Drugs ran out of appropriated funds April 3 and a hiring freeze was imposed, halting a recently launched aggressive recruitment program aimed at boosting staff by 50% to reduce a backlog.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.